Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

Clinical trial NCT00651326 · TERMINATED

Trial details

NCT number: NCT00651326
Sponsor: NCIC Clinical Trials Group
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2008-06-02
Primary completion: 2010-05-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.